{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:45:04Z","timestamp":1772012704592,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"10-11","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.clinbiochem.2014.02.008","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T11:16:54Z","timestamp":1392895014000},"page":"909-915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The role of prostatic inflammation biomarkers in the diagnosis of prostate diseases"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8288-5468","authenticated-orcid":false,"given":"Razvan","family":"Bardan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-8130","authenticated-orcid":false,"given":"Raluca","family":"Dumache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alis","family":"Dema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alin","family":"Cumpanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viorel","family":"Bucuras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0005","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.eururo.2007.06.038","article-title":"Inflammation and chronic prostatic diseases: evidence for a link?","volume":"52","author":"Sciarra","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0010","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000478-198808000-00003","article-title":"Normal histology of the prostate","volume":"12","author":"McNeal","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0015","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","article-title":"The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial","volume":"54","author":"Nickel","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0025","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","article-title":"Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?","volume":"51","author":"Kramer","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0030","first-page":"96","article-title":"Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia","volume":"66","author":"Theyer","year":"1992","journal-title":"Lab Invest"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0035","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.eursup.2009.11.004","article-title":"Should we investigate prostatic inflammation for the management of benign prostatic hyperplasia?","volume":"8","author":"Robert","year":"2009","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0040","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.LAB.0000081388.40145.65","article-title":"Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue","volume":"83","author":"Steiner","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1097-0045(20000615)44:1<49::AID-PROS7>3.0.CO;2-7","article-title":"PSA is a candidate self-antigen in autoimmune chronic prostatitis\/chronic pelvic pain syndrome","volume":"44","author":"Ponniah","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11884-013-0179-6","article-title":"The role of inflammation in the progression of benign prostatic hyperplasia","volume":"8","author":"De Nunzio","year":"2013","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0055","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/carcin\/bgh317","article-title":"Prostate carcinogenesis and inflammation: emerging insights","volume":"26","author":"Palapattu","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eursup.2013.08.002","article-title":"Why and how to evaluate chronic prostatic inflammation","volume":"12","author":"Ficarra","year":"2013","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pros.10317","article-title":"Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer","volume":"58","author":"Konig","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pros.20710","article-title":"The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells","volume":"68","author":"Kundu","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/PDM.0b013e31816f6352","article-title":"BPH gene expression profile associated to prostate gland volume","volume":"17","author":"Descazeaud","year":"2008","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0085","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0022-5347(17)41924-0","article-title":"The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis","volume":"140","author":"Naslund","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0090","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ajcn\/86.3.843S","article-title":"Obesity, metabolic syndrome, and prostate cancer","volume":"86","author":"Hsing","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0095","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.juro.2006.11.065","article-title":"Race\/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial","volume":"177","author":"Kristal","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0100","first-page":"141","article-title":"Prostatic corpora amylacea and crystalloids: similarities and differences on ultrastructural and histochemical studies","volume":"28","author":"Drachenberg","year":"1996","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0105","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","article-title":"Proliferative inflammatory atrophy of the prostate","volume":"155","author":"De Marzo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.2002.tb04108.x","article-title":"Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention","volume":"963","author":"Montironi","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0120","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.eururo.2006.07.016","article-title":"Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis\/chronic pelvic pain syndrome and benign prostatic hyperplasia","volume":"51","author":"Penna","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0125","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0090-4295(98)00390-2","article-title":"Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis\/chronic pelvic pain syndrome","volume":"52","author":"Alexander","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000052415","article-title":"Non-inflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue","volume":"39","author":"John","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0135","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1097\/01.ju.0000127760.87421.e9","article-title":"Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 gene in symptomatic benign prostatic hyperplasia","volume":"171","author":"Taoka","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eururo.2004.08.024","article-title":"Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)","volume":"47","author":"Di Silverio","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0145","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00262-009-0658-y","article-title":"Polymorphisms of proinflammatory genes and prostate cancer risk: a pharmacogenomic approach","volume":"58","author":"Caruso","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0150","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0155","doi-asserted-by":"crossref","first-page":"11733","DOI":"10.1073\/pnas.91.24.11733","article-title":"Cytidine methylation of regulatory sequences near the pi-class glutathione S transferase gene accompanies human prostatic carcinogenesis","volume":"91","author":"Lee","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1464-410x.2001.02231.x","article-title":"Inducible nitric oxide synthase expression in BPH, low and high grade PIN and prostate carcinoma","volume":"88","author":"Baltaci","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0165","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cell.2005.12.032","article-title":"Macrophage\/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway","volume":"124","author":"Zhu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2008.01.003","article-title":"Pathways connecting inflammation and cancer","volume":"18","author":"Allavena","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MOU.0b013e3282f9b3b7","article-title":"Inflammation, infection, and prostate cancer","volume":"18","author":"Klein","year":"2008","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00345-007-0203-6","article-title":"Biomarkers for prostate cancer","volume":"25","author":"Schiffer","year":"2007","journal-title":"World J Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9440(10)64535-X","article-title":"Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia","volume":"157","author":"Giri","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0190","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/pros.10204","article-title":"Cellular senescence in the pathogenesis of benign prostatic hyperplasia","volume":"55","author":"Castro","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/theoncologist.2011-0321","article-title":"Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer","volume":"17","author":"Saylor","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pros.10084","article-title":"Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation","volume":"52","author":"Kramer","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X","article-title":"Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue","volume":"191","author":"Hobisch","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0210","first-page":"1773","article-title":"Interleukin-6 induces androgen responsiveness in prostate cancer cell through up-regulation of androgen receptor expression","volume":"7","author":"Lin","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-4295(97)00491-3","article-title":"Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells","volume":"51","author":"Ferrer","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9440(10)61681-1","article-title":"Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia","volume":"159","author":"Giri","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/pros.20051","article-title":"Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia","volume":"60","author":"Castro","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0230","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2605.2010.01121.x","article-title":"Ultrasonographic and clinical correlates of seminal plasma interleukin-8 levels in patients attending an andrology clinic for infertility","volume":"34","author":"Lotti","year":"2011","journal-title":"Int J Androl"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0235","first-page":"66","article-title":"Induction of 3-beta-hydroxysteroid dehydrogenase\/delta-5-delta-4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13","volume":"13","author":"Gingras","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0240","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/pros.10020","article-title":"Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate","volume":"49","author":"Handisurya","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-5347(17)40631-8","article-title":"Divergent effects of interferons on the growth of human benign prostatic hyperplasia cells in primary culture","volume":"141","author":"Deshpande","year":"1989","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.clinbiochem.2014.02.008_bb0250","first-page":"1714","article-title":"ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion","volume":"40","author":"Xiao","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0255","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1097-0045(19990601)39:4<285::AID-PROS9>3.0.CO;2-7","article-title":"Transforming growth factor-beta in benign and malignant prostate","volume":"39","author":"Lee","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0260","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1097-0045(19991001)41:2<110::AID-PROS5>3.0.CO;2-X","article-title":"Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGFbeta)","volume":"41","author":"Klingler","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0265","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mad.2004.09.023","article-title":"Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation","volume":"126","author":"Untergasser","year":"2005","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0270","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0022-5347(01)62092-5","article-title":"Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma","volume":"161","author":"Adler","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0275","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.mehy.2007.08.022","article-title":"Chronic inflammation in benign prostatic hyperplasia: implications for therapy","volume":"70","author":"Wang","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/pros.20110","article-title":"Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"62","author":"Rohrmann","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0285","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/aje\/kwp406","article-title":"Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: Results from the Prostate Cancer Prevention Trial","volume":"171","author":"Schenk","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0290","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/cncr.23461","article-title":"C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial","volume":"112","author":"Beer","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0295","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10408369991239187","article-title":"Phospholipase A2: its usefulness in laboratory diagnostics","volume":"36","author":"Kaiser","year":"1999","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0300","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s10753-011-9418-1","article-title":"Serum levels of secreted group IIA phospholipase A2 in benign prostatic hyperplasia and prostate cancer: a biomarker for inflammation or neoplasia?","volume":"35","author":"Menschikowski","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0305","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/pros.21081","article-title":"Monocyte chemotactic protein-1 (MCP-1\/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia","volume":"70","author":"Fujita","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0310","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/0962935031000097745","article-title":"Malondialdehyde in benign prostate hypertrophy: a useful marker?","volume":"12","author":"Merendino","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0315","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/pros.21387","article-title":"Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia","volume":"71","author":"Robert","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0320","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1590\/S1677-55382011000500008","article-title":"Inflammation and endothelial activation in benign prostatic hyperplasia and prostate cancer","volume":"37","author":"Pace","year":"2011","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.clinbiochem.2014.02.008_bb0325","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/pros.21502","article-title":"Oxidative stress\u2014cause or consequence of male genital tract disorders?","volume":"72","author":"Kullisaar","year":"2012","journal-title":"Prostate"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:43:09Z","timestamp":1757864589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912014000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":65,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0009912014000691"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.02.008","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of prostatic inflammation biomarkers in the diagnosis of prostate diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}